FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384695969> ?p ?o ?g. }

• W4384695969 endingPage "9" @default.
• W4384695969 startingPage "9" @default.
• W4384695969 abstract "Objectives The percentage of pelvic lymph node positivity in cervical cancer patients varies from 19% in early stages to 68% in advanced cases. Thirty three percent of patients will develop recurrence within 2 years following therapy and 5-year relative survival for patients with affected regional lymph nodes is 57%. Hence, pelvic lymph nodes need to be included in the definitive plan of radiation treatment for better disease control and longer survival. With conventional radiation therapy, dose escalation was not possible because of small bowel constraints. With higher conformity of intensity modulated radiotherapy technique (IMRT), doses to pelvic and abdominal organs can be minimized. The added advantage of simultaneous integrated boost (SIB) is that high dose per fraction is delivered to the gross disease and low dose to the microscopic disease, thereby reducing the total treatment time and improving the therapeutic ratio. Material and Methods Forty one patients presenting to the Department of Radiation Oncology, between January 2016 and June 2017, with newly biopsy proven carcinoma cervix Stage IB to IVA were enrolled in the study and all the investigations were performed. The radiation dose was delivered using volumetric modulated arc therapy plan to a dose of 5000 cGy in 25 fractions to the whole pelvis and 5500 cGy in 25 fractions at 220 cGy per fraction to the involved nodes using SIB along with weekly cisplatin at 40 mg/m 2 . After completion of external beam radiation, all the patients received three fractions of brachytherapy to a total dose of 21 Gy. Acute toxicities were assessed using RTOG criteria. At 3 months after completion of treatment, all the patients had been followed up with DW MRI of abdomen and pelvis to assess the response. Results Of the 41 carcinoma cervix patients with significantly positive lymph nodes treated with SIB VMAT, 9.8% of the patients (4 patients) had residual nodal disease, 87.8% of the patients (36 patients) had complete response, 19.5% (8 patients) had residual disease of primary disease, and 78% (32 patients) had complete response at 3 months after completion of treatment with only Grade – I and Grade – II toxicities. Conclusion Treatment with SIB VMAT in carcinoma cervix patients with significant pelvic lymph nodes shows very good response with acceptable acute toxicities. But longer follow-up period is required to see if this response translates into better DFS and OS." @default.
• W4384695969 created "2023-07-20" @default.
• W4384695969 creator A5002325106 @default.
• W4384695969 creator A5027466318 @default.
• W4384695969 creator A5061748853 @default.
• W4384695969 creator A5063804263 @default.
• W4384695969 date "2023-07-18" @default.
• W4384695969 modified "2023-09-26" @default.
• W4384695969 title "Indian data on response of positive pelvic lymph nodes in carcinoma cervix patients treated with simultaneous integrated boost using volumetric modulated arc radiation therapy" @default.
• W4384695969 cites W2019607817 @default.
• W4384695969 cites W2106787323 @default.
• W4384695969 cites W2135045906 @default.
• W4384695969 cites W2147722125 @default.
• W4384695969 cites W2151079567 @default.
• W4384695969 cites W2170871177 @default.
• W4384695969 cites W2906772792 @default.
• W4384695969 cites W2945407679 @default.
• W4384695969 doi "https://doi.org/10.25259/asjo-2022-26-(370)" @default.
• W4384695969 hasPublicationYear "2023" @default.
• W4384695969 type Work @default.
• W4384695969 citedByCount "0" @default.
• W4384695969 crossrefType "journal-article" @default.
• W4384695969 hasAuthorship W4384695969A5002325106 @default.
• W4384695969 hasAuthorship W4384695969A5027466318 @default.
• W4384695969 hasAuthorship W4384695969A5061748853 @default.
• W4384695969 hasAuthorship W4384695969A5063804263 @default.
• W4384695969 hasBestOaLocation W43846959691 @default.
• W4384695969 hasConcept C121608353 @default.
• W4384695969 hasConcept C126322002 @default.
• W4384695969 hasConcept C126838900 @default.
• W4384695969 hasConcept C141071460 @default.
• W4384695969 hasConcept C142724271 @default.
• W4384695969 hasConcept C201645570 @default.
• W4384695969 hasConcept C2777416452 @default.
• W4384695969 hasConcept C2777546739 @default.
• W4384695969 hasConcept C2777740455 @default.
• W4384695969 hasConcept C2778220009 @default.
• W4384695969 hasConcept C2778357063 @default.
• W4384695969 hasConcept C2779720271 @default.
• W4384695969 hasConcept C2780849966 @default.
• W4384695969 hasConcept C2989005 @default.
• W4384695969 hasConcept C509974204 @default.
• W4384695969 hasConcept C71924100 @default.
• W4384695969 hasConceptScore W4384695969C121608353 @default.
• W4384695969 hasConceptScore W4384695969C126322002 @default.
• W4384695969 hasConceptScore W4384695969C126838900 @default.
• W4384695969 hasConceptScore W4384695969C141071460 @default.
• W4384695969 hasConceptScore W4384695969C142724271 @default.
• W4384695969 hasConceptScore W4384695969C201645570 @default.
• W4384695969 hasConceptScore W4384695969C2777416452 @default.
• W4384695969 hasConceptScore W4384695969C2777546739 @default.
• W4384695969 hasConceptScore W4384695969C2777740455 @default.
• W4384695969 hasConceptScore W4384695969C2778220009 @default.
• W4384695969 hasConceptScore W4384695969C2778357063 @default.
• W4384695969 hasConceptScore W4384695969C2779720271 @default.
• W4384695969 hasConceptScore W4384695969C2780849966 @default.
• W4384695969 hasConceptScore W4384695969C2989005 @default.
• W4384695969 hasConceptScore W4384695969C509974204 @default.
• W4384695969 hasConceptScore W4384695969C71924100 @default.
• W4384695969 hasLocation W43846959691 @default.
• W4384695969 hasOpenAccess W4384695969 @default.
• W4384695969 hasPrimaryLocation W43846959691 @default.
• W4384695969 hasRelatedWork W1966946680 @default.
• W4384695969 hasRelatedWork W2019388282 @default.
• W4384695969 hasRelatedWork W2117428097 @default.
• W4384695969 hasRelatedWork W2152114768 @default.
• W4384695969 hasRelatedWork W2437812263 @default.
• W4384695969 hasRelatedWork W2971468854 @default.
• W4384695969 hasRelatedWork W3028896438 @default.
• W4384695969 hasRelatedWork W3093971735 @default.
• W4384695969 hasRelatedWork W3110899715 @default.
• W4384695969 hasRelatedWork W3147330880 @default.
• W4384695969 hasVolume "9" @default.
• W4384695969 isParatext "false" @default.
• W4384695969 isRetracted "false" @default.
• W4384695969 workType "article" @default.